5-Bromo-6-fluoro-2-methyl-2H-indazole

Catalog No.: 
ACVMXU207
CAS No.: 
2091272-22-7
Molecular Formula: 
C8H6BrFN2
Molecular Weight: 
229.05
5-Bromo-6-fluoro-2-methyl-2H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$143.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-fluoro-2-methyl-2H-indazole
IUPAC Name5-bromo-6-fluoro-2-methyl-2H-indazole
MDL No.MFCD30802371
Molecular FormulaC8H6BrFN2
Molecular Weight229.05
SMILESCN1N=C2C=C(F)C(Br)=CC2=C1
InChI KeyROOLMMOBFMVQTM-UHFFFAOYSA-N
Synonym"2H-Indazole, 5-bromo-6-fluoro-2-methyl- ";5-bromo-6-fluoro-2-methyl-2H-ondazole
CAS No.2091272-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVMXU207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKCHP385 route compound structure diagram
    ACKCHP385105391-70-6In Stock
  4. Then
  5. ACVMXU207 route product structure diagram
    ACVMXU2072091272-22-7In Stock
Inquiry

2. ACVMXU207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACKCHP385 route compound structure diagram
    ACKCHP385105391-70-6In Stock
  4. Then
  5. ACVMXU207 route product structure diagram
    ACVMXU2072091272-22-7In Stock
Inquiry

3. ACVMXU207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKCHP385 route compound structure diagram
    ACKCHP385105391-70-6In Stock
  4. Then
  5. ACVMXU207 route product structure diagram
    ACVMXU2072091272-22-7In Stock
Inquiry

Comments (0)